Bridges Investment Management Inc Pfizer Inc Transaction History

Bridges Investment Management Inc

$7.07 Billion
Q3 2024

A detailed history of Bridges Investment Management Inc transactions in Pfizer Inc stock. As of the latest transaction made, Bridges Investment Management Inc holds 84,556 shares of PFE stock, worth $2.11 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

84,556

Previous 84,412 0.17%

Holding current value

$2.11 Million

Previous $2.36 Million 3.64%

% of portfolio

0.03%

Previous 0.04%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$27.7 - $31.39 $3,988 - $4,520	144 Added 0.17%	84,556 $2.45 Million
Q2 2024 Aug 12, 2024	BUY	$25.26 - $29.6 $960,183 - $1.13 Million	38,012 Added 81.92%	84,412 $2.36 Million
Q4 2023 Jan 23, 2024	SELL	$26.13 - $33.94 $91,455 - $118,789	-3,500 Reduced 7.01%	46,400 $1.34 Million
Q3 2023 Oct 24, 2023	SELL	$32.09 - $37.51 $79,069 - $92,424	-2,464 Reduced 4.71%	49,900 $1.66 Million
Q2 2023 Jul 07, 2023	SELL	$36.12 - $41.79 $7,223 - $8,358	-200 Reduced 0.38%	52,364 $1.92 Million
Q1 2023 Apr 28, 2023	SELL	$39.39 - $51.28 $82,719 - $107,688	-2,100 Reduced 3.84%	52,564 $2.14 Million
Q4 2022 Feb 13, 2023	SELL	$41.75 - $54.5 $79,366 - $103,604	-1,901 Reduced 3.36%	54,664 $2.8 Million
Q3 2022 Oct 21, 2022	SELL	$43.76 - $53.42 $40,959 - $50,001	-936 Reduced 1.63%	56,565 $2.48 Million
Q2 2022 Jul 12, 2022	SELL	$46.53 - $55.17 $37,224 - $44,136	-800 Reduced 1.37%	57,501 $3.02 Million
Q1 2022 Apr 08, 2022	SELL	$45.75 - $56.69 $118,904 - $147,337	-2,599 Reduced 4.27%	58,301 $3.02 Million
Q4 2021 Feb 01, 2022	SELL	$41.32 - $61.25 $31,361 - $46,488	-759 Reduced 1.23%	60,900 $3.6 Million
Q3 2021 Nov 12, 2021	SELL	$39.25 - $50.42 $7,732 - $9,932	-197 Reduced 0.32%	61,659 $2.65 Million
Q2 2021 Jul 19, 2021	SELL	$35.91 - $40.68 $35,766 - $40,517	-996 Reduced 1.58%	61,856 $2.42 Million
Q1 2021 May 05, 2021	SELL	$33.49 - $37.77 $178,066 - $200,823	-5,317 Reduced 7.8%	62,852 $2.28 Million
Q4 2020 Feb 12, 2021	SELL	$33.47 - $42.56 $150,380 - $191,222	-4,493 Reduced 6.18%	68,169 $2.51 Million
Q3 2020 Nov 12, 2020	SELL	$31.75 - $37.25 $31,623 - $37,101	-996 Reduced 1.35%	72,662 $2.67 Million
Q2 2020 Aug 10, 2020	SELL	$30.12 - $36.54 $247,465 - $300,212	-8,216 Reduced 10.03%	73,658 $2.41 Million
Q1 2020 May 12, 2020	SELL	$27.03 - $38.62 $923,371 - $1.32 Million	-34,161 Reduced 29.44%	81,874 $2.67 Million
Q4 2019 Feb 18, 2020	SELL	$32.92 - $37.36 $15,571 - $17,671	-473 Reduced 0.41%	116,035 $4.55 Million
Q3 2019 Nov 12, 2019	SELL	$32.49 - $42.13 $535,630 - $694,555	-16,486 Reduced 12.4%	116,508 $4.19 Million
Q2 2019 Aug 07, 2019	SELL	$36.98 - $41.52 $702 - $788	-19 Reduced 0.01%	132,994 $5.76 Million
Q1 2019 May 01, 2019	SELL	$37.5 - $41.2 $442,687 - $486,366	-11,805 Reduced 8.15%	133,013 $5.65 Million
Q4 2018 Feb 11, 2019	SELL	$38.47 - $43.86 $128,643 - $146,667	-3,344 Reduced 2.26%	144,818 $6.32 Million
Q3 2018 Nov 15, 2018	SELL	$34.47 - $41.81 $139,672 - $169,414	-4,052 Reduced 2.66%	148,162 $6.53 Million
Q2 2018 Aug 15, 2018	SELL	$32.98 - $35.16 $143,397 - $152,875	-4,348 Reduced 2.78%	152,214 $5.52 Million
Q1 2018 Apr 25, 2018	BUY	$31.91 - $37.02 $1.17 Million - $1.36 Million	36,602 Added 30.51%	156,562 $5.56 Million
Q4 2017 Feb 09, 2018	BUY	$33.26 - $35.29 $442,624 - $469,639	13,308 Added 12.48%	119,960 $4.35 Million
Q3 2017 Oct 05, 2017	BUY	$31.0 - $34.15 $1.67 Million - $1.83 Million	53,710 Added 101.45%	106,652 $3.81 Million
Q3 2017 Oct 02, 2017	BUY	$31.0 - $34.15 $1.64 Million - $1.81 Million	52,942	52,942 $1.89 Million

Others Institutions Holding PFE

# of Institutions

3,256

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $140B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridges Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bridges Investment Management Inc with notifications on news.

Account

Bridges Investment Management Inc Pfizer Inc Transaction History